Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 4/20 | 0.37 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6141545 | 0.91 | PRKCA (0.37) | ALDH1A1LMNAPRKCA | |
| SCHEMBL7478992 | 0.89 | PRKCA (0.34) | ALDH1A1LMNAPRKCA | |
| SCHEMBL1838799 | 0.89 | PRKCA (0.50) | PRKCA | |
| SCHEMBL23156004 | 0.87 | PRKCA (0.33) | ALDH1A1LMNAPRKCA | |
| SCHEMBL26658338 | 0.86 | PRKCA (0.53) | ALDH1A1LMNAPRKCA | |
| SCHEMBL12597761 | 0.84 | ENPP2 (0.50) | — | |
| SCHEMBL25276652 | 0.84 | ALDH1A1 (0.52) | ALDH1A1LMNAPRKCA | |
| SCHEMBL17866531 | 0.82 | ALDH1A1 (0.46) | ALDH1A1LMNAPRKCA | |
| SCHEMBL19034592 | 0.82 | ADRB2 (0.37) | — | |
| SCHEMBL19034633 | 0.82 | ABCB1 (0.31) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2064295-A1 | A WATERBORNE BINDER COMPOSITION AND USE THEREOF | Perstorp Specialty Chemicals AB (SE) | 2009-06-03 | — | — | EP | claimed |
| WO-2008054277-A1 | A WATERBORNE BINDER COMPOSITION AND USE THEREOF | PERSTORP SPECIALTY CHEMICALS AB (SE) | 2008-05-08 | — | — | WO | claimed |
| EP-4619017-A1 | ANTIBIOTIC-RESISTANT BACTERIA | Imperial College Innovations Limited (GB) | 2025-09-24 | — | — | EP | disclosed |
| US-20240366723-A1 | COMBINATION THERAPY FOR THE TREATMENT OF ENTERIC NEUROPATHIES | UNIVERSITÉ DU QUÉBEC À MONTRÉAL (CA) | 2024-11-07 | — | — | US | disclosed |
| WO-2024105412-A1 | ANTIBIOTIC-RESISTANT BACTERIA | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2024-05-23 | — | — | WO | disclosed |
| EP-4355354-A1 | COMBINATION THERAPY FOR THE TREATMENT OF ENTERIC NEUROPATHIES | Transfert Plus Limited Partnership (CA) | 2024-04-24 | — | — | EP | disclosed |
| WO-2022261765-A1 | COMBINATION THERAPY FOR THE TREATMENT OF ENTERIC NEUROPATHIES | SORET RODOLPHE (CA) | 2022-12-22 | — | — | WO | disclosed |
| EP-2740497-B1 | Medical adhesive compound | AESCULAP AG (DE) | 2017-12-06 | — | — | EP | disclosed |
| EP-2366721-B1 | Medical kit for use during negative pressure wound therapy | AESCULAP AG (DE) | 2016-08-10 | — | — | EP | disclosed |
| EP-2223706-B1 | Medical adhesive compound | AESCULAP AG (DE) | 2014-09-03 | — | — | EP | disclosed |
| EP-2740497-A1 | Medical adhesive compound | Aesculap AG (DE) | 2014-06-11 | — | — | EP | disclosed |
| EP-0584159-A1 | NUTRIENT PREPARATION. | FRESENIUS AG (DE) | 1994-03-02 | — | — | EP | disclosed |
| US-5248531-A | TRIGLYCERIDE | TERUMO KABUSHIKI KAISHA (JP) | 1993-09-28 | — | — | US | disclosed |
| EP-0340305-B1 | HEMOLYSIS INHIBITOR AND PLASTICIZER | Kao Corporation (JP) | 1993-04-21 | — | — | EP | disclosed |
| WO-1992020241-A1 | NUTRIENT PREPARATION | FRESENIUS AG (DE) | 1992-11-26 | — | — | WO | disclosed |
| US-5079002-A | During blood preservation; ccontacting erythrocyte with a triglyceride compound | TERUMO KABUSHIKI KAISHA (JP) | 1992-01-07 | — | — | US | disclosed |
| US-4927754-A | Method for selectively increasing the ratio of single major components of teicoplanin A2 complex | GRUPPO LEPETIT S.P.A. (IT) | 1990-05-22 | — | — | US | disclosed |
| EP-0204179-B1 | METHOD FOR SELECTIVELY INCREASING THE RATIO OF SINGLE MAJOR COMPONENTS OF TEICOPLANIN A2 COMPLEX | GRUPPO LEPETIT S.p.A. (IT) | 1989-11-08 | — | — | EP | disclosed |
| EP-0340305-A1 | HEMOLYSIS INHIBITOR AND PLASTICIZER | Kao Corporation (JP) | 1989-11-08 | — | — | EP | disclosed |
| EP-0204179-A1 | Method for selectively increasing the ratio of single major components of teicoplanin A2 complex | GRUPPO LEPETIT S.p.A. (IT) | 1986-12-10 | — | — | EP | disclosed |